In Charity News

On Saturday, we got together at London Zoo with a great group of families to launch ‘little brainstrust’ – our new service dedicated to helping families where a child has been diagnosed with a brain tumour.

This is the result of 7 years of accumlated insight at brainstrust, ongoing input from families, expert advice and an exciting collaboration with the Smiley Riley Fund.

Dedicated help with practical, emotional and financial challenges. 

Little Brainstrust

At brainstrust we know that a brain tumour diagnosis is a huge blow for loved ones, and this can be even more devastating when the patient is a child. The brain tumour diagnosis and associated treatments bring a huge range of difficult practical, emotional and financial challenges for the whole family and young survivors are often left with a number of disabilities or special needs.

Indeed, 500 children a year are diagnosed with a brain tumour, and there are innumerable families living with the disease. Two thirds of children diagnosed are left with a disability. Families can find communication difficult, and awareness of brain tumours in children is low; this is despite the fact that brain tumours now kill more children than any other illness in the UK.

It’s because of this that ‘little brainstrust’ is needed. brain tumour support for children and families

Helen Bulbeck, co-founder and director of services at brainstrust says, ‘When a family faces a brain tumour diagnosis, they have many unique challenges, particularly around communication, living with long term effects, feeling afraid and feeling alone. This dedicated, logical extension of brainstrust’s work will make sure that this group of people get the focussed help that they need. It’s also great that we’ve been able to find a partner to help us deliver the service. The Smiley Riley Fund was founded after 20 month old Riley Plant sadly lost his life to a brain tumour: they have first hand experience of the issues that we need to tackle.’

On Saturday ‘little brainstrust’ launched at the ZSL London Zoo where a group of children who’ve been battling a brain tumour, along with their families, joined us for a fantastic day out. It was a wonderful opportunity for families to meet others who really understand what life is like at every stage of the brain tumour journey, and also to find out more about how ‘little brainstrust’ can help.

brain tumour support for children and familiesAt the heart of the service is the new ‘little brainstrust’ website
. The site has information on everything that families need when faced with this devastating scenario from tips on communicating to advice on some of the financial help available. The partnership with the Smiley Riley Fund has also allowed us to launch a new dedicated fund that offers small grants to help with the additional costs that come from regular travel to hospital such as extra childcare and parking.

There’s a new Little Brain Box available free of charge that is full of really useful resources to help families keep on top of things as they deal with the diagnosis. And of course it’s all backed up by our 24/7 coaching led support available by phone or email. We will also be extending our programme of popular ‘Meet Ups’ to include events that are entertaining and useful to familes with children battling a brain tumour diagnosis.

Leaving no family feeling lost or alone

We’re confident that this new dedicated national service has the potential to leave no family feeling lost or alone in their journey. To find out more about ‘little brainstrust’ and how to support our work here, pay a visit to the dedicated website at


You can also find out more about the Smiley Riley Fund over at

brain tumour support for children



The Brain Tumour Data Dashboard lets you explore up -to-date, population level data about the brain tumours diagnosed in England between 2013 and 2015. Using the drop down menus on the left you can select different groups of patients to view in the charts below. In these charts the number of patients for every 100 diagnoses is displayed as images of people. Patients have been grouped by date of diagnosis, type of tumour, age, gender, and region in England.

For each group of patients you can explore the different routes to diagnosis, the proportion of those who received chemotherapy or radiotherapy, as well as the survival of the patients within each group. For more information about what these metrics mean please see the glossary.

How to use

  1. Select the year of diagnosis using the drop down menu.
  2. Select your patient group of interest from the four drop down menus in the following order:
    1. Tumour group
    2. Age at diagnosis
    3. Region of England
    4. Gender of patient
  3. To view a second chart to compare different groups of patients, click the ‘compare’ button.The second chart will appear below the first chart.

*Note that the tool is best used on a laptop or tablet rather than a mobile phone*

Unavailable data

Some of the data in these charts is not available.There are two main reasons for this:

  1. How the data has been grouped

If you cannot select a patient group from the drop down menus, the data is unavailable because of how the data has been organised.

Public Health England has grouped the data like a branching tree. The bottom of the tree contains all the patients with brain tumours, and then each branch divides the data by a certain characteristics, like age, or location of tumour. But the data is divided in an order, starting with location of the tumour (endocrine or brain), then by age, region, and gender. Age is at the start because it makes a bigger difference to survival rates and treatment rates than gender or region. Sometimes, after the data has been split by type of tumour and age, there is not enough data to be split again. This is because to protect patient confidentiality groups cannot contain less than 100 patients. Because some groups cannot be split further, you cannot create ‘totals’ for everyone by region or gender. For example, you cannot see results for all ages by region, or all brain tumours by gender. If these totals were calculated and released, it might be possible to identify patients, which is why Public Health England cannot release this data.

  1. Statistical reasons and data availability

If you can select a patient group from the chart menus, but the chart does not display, the data is unavailable for one of several reasons:

  1. Data is not yet available for the selected year from Public Health England.
  2. Data is not available because the data quality is too poor to release this statistic.
  3. Data is not available as the statistic is not appropriate for this group.
  4. Data is not available because the standard error of the estimate was greater than 20% and so the estimate has been supressed.

Up to date brain tumour data

Brain tumour data may influence the decisions you make about your care. Data also helps you understand the bigger picture, or landscape, in which you find yourself.

Brain tumour data and statistics influence the focus, and work of organisations like brainstrust. The information helps us to understand the scale and impact of the problems we are setting out to solve.

This tool helps you understand the landscape in which you find yourself having been diagnosed with a brain tumour. This landscape can be particularly tricky to navigate as there are many different types of brain tumour, all of which have a different impact.

The information you see represents the most up-to-date, official, population level brain tumour data available for England. Over time we will be adding to the brain tumour data available and publishing reports, with recommendations, as a result of what we learn from this data.

The data behind this content has come from Public Health England’s National Cancer Registration and Analysis Service (NCRAS) and is a direct result of the ‘Get Data Out’ project.

This project provides anonymised population level brain tumour data for public use in the form of standard output tables, accessible here:


The number or rate (per head of population) of new cases of a disease diagnosed in a given population during a specified time period (usually a calendar year). The crude rate is the total number of cases divided by the mid-year population, usually expressed per 100,000 population.


Malignant tumours which grow by invasion into surrounding tissues and have the ability to metastasise to distant sites


The number or rate (per head of population) of deaths in a given population during a specified time period (usually a calendar year). The crude rate is the total number of deaths divided by the mid-year population, usually expressed per 100,000 population.


Not cancerousNon-malignant tumours may grow larger but do not spread to other parts of the body.


The length of time from the date of diagnosis for a disease, such as cancer, that patients diagnosed with the disease are still alive. In a clinical trial, measuring the survival is one way to see how well a new treatment works. Also called ‘overall survival’ or ‘OS’.

Routes to Diagnosis

Under the ‘Routes to Diagnosis’ tab in the Brain Tumour Data Dashboard, you can explore the ways patients have been diagnosed with brain tumours. There are many ways, or routes, for cancers to be diagnosed in the NHS. A ‘route to diagnosis’ is the series of events between a patient and the healthcare system that leads to a diagnosis of cancer. The routes include:

  1. Two Week Wait

Patients are urgently referred by their GP for suspected cancer via the Two Week Wait system and are seen by a specialist within 2 weeks where they are diagnosed.

  1. GP referral

Diagnosis via a GP referral includes routine and urgent referrals where the patient was not referred under the Two Week Wait system.

  1. Emergency Presentation

Cancers can be diagnosed via emergency situations such as via A&E, emergency GP referral, emergency transfer or emergency admission.

  1. Outpatient

Outpatient cancer diagnoses include diagnoses via an elective route which started with an outpatient appointment that is either a self-referral or consultant to consultant referral. (It does not include those under the Two Week Wait referral system).

  1. Inpatient elective

Diagnosis via an inpatient elective route is where diagnosis occurs after the patient has been admitted into secondary care from a waiting list, or where the admission is booked or planned.

  1. Death Certificate Only

Diagnoses made by Death Certificate Only are made where there is no more information about the cancer diagnosis other than the cancer related death notifications. The date of diagnosis is the same as that of the date of death.

  1. Unknown

For some patients with a cancer diagnosis, there is no relevant data available to understand the route to diagnosis.


More information

If any of the statistical terms in this section of the brainstrust website are hard to understand, we recommend looking them up here:

Cancer Research UK’s Cancer Statistics Explained

If you are looking for help understanding terms relating specifically to brain tumours, and treatment, then the brainstrust glossary is available here: